Daniel Spiegel, MD, MBA
Sr. Director, New Venture Investments
Daniel leads investments in health care technology, diagnostics, non-invasive medical devices and technology-enabled services companies. Prior to joining DaVita Venture Group, he focused on driving growth, policy and tech strategy within DaVita’s rapidly evolving home dialysis business, including leading DaVita’s first application of clinical AI.
Prior to DaVita, Daniel led strategy and business development for a health care analytics startup, establishing partnerships and fundraising. Before this, he was a strategy consultant at Bain & Company.
Daniel holds an MD from the University of Texas Southwestern Medical Center where he was an Alpha Omega Alpha inductee and an MBA from the University of Texas at Austin. He completed his undergraduate studies at Washington University in St. Louis.